There
is an increasing demand for effective noninvasive diagnosis
against common pulmonary diseases, which are rising sharply due to
the serious air pollution. Human neutrophil elastase (HNE), a typical
protease highly involved in pulmonary inflammatory diseases and lung
cancer, is a potential predictor for disease progression. Currently,
few of the HNE-targeting probes are applicable in vivo due to the limitation in sensitivity and biocompatibility. Herein,
we reported the achievement of in vitro detection
and in vivo imaging of HNE by incorporating the HNE-specific
peptide substrate, quantum dots (QDs), and organic dyes into the fluorescence
resonance energy transfer (FRET) system. The refined nanoprobe, termed QDP, could specifically measure the HNE with excellent sensitivity
of 7.15 pM in aqueous solution and successfully image the endogenous
and exogenous HNE in living cells. In addition, this nanoprobe enabled
HNE imaging in mouse models of lung cancer and acute lung injury,
and the HNE activity at high temporal and spatial resolution was continuously
monitored. Most importantly, QDP successfully discriminated
the serums of patients with lung diseases from those of the healthy
controls based on the HNE activity determination. Overall, this study
demonstrates the advantages of a FRET-system-based nanoprobe in imaging
performance and provides an applicable tool for in vivo HNE detection and pulmonary disease diagnosis.